fruquintinib (Fruzaqla) Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12
  • InChIKey: BALLNEJQLSTPIO-UHFFFAOYSA-N
  • Mol. Mass: 393.4
  • ALogP: 3.85
  • ChEMBL Molecules:
    fruquintinib  
    fruquintinib  
More Chemistry

Pharmacology

Alternative names

fruquintinib | fruquitinib | hmpl-013

Organizations (34)

Research & Development (33)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (29)

Approved Indications (1)


 

Colorectal Neoplasms

Experimental Indications - Clinical Trial Phases 1-4 (29)


 

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 4)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2/Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 4)

DNA Mismatch Repair (Phase 2)

Drug Interactions (Phase 1)

Drugs, Investigational (Phase 2)

Endometrial Neoplasms (Phase 1/Phase 2)

Esophageal Neoplasms (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 2)

Food-Drug Interactions (Phase 1)

Healthy Volunteers (Phase 1)

Immunotherapy (Phase 1/Phase 2)

Kidney Failure, Chronic (Phase 1)

Liver Diseases (Phase 1)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 1/Phase 2)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Patient Safety (Phase 4)

Pharmacology (Phase 1)

Rectal Neoplasms (Phase 2)

Sarcoma (Phase 2)

Stomach Neoplasms (Phase 3)

Triple Negative Breast Neoplasms (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 90
  • # of Trial Organizations: 33

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue